{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:25:53Z","timestamp":1763547953820,"version":"3.45.0"},"reference-count":20,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Pulmonary adenocarcinoma in dogs, particularly in advanced stages, carries a poor prognosis with limited therapeutic options. Immunotherapeutic approaches that activate natural killer (NK) cells may provide additional clinical benefit. This report describes the clinical response and survival outcome of a 9-year-old neutered male Welsh Corgi with late-stage pulmonary adenocarcinoma treated with combined chemotherapy and cytokine-based NK cell-activating immunotherapy. The dog presented with intermittent coughing, dyspnea, and cyanosis. Imaging revealed a large pulmonary mass with suspected nodal metastasis (stage III, T4N1M0). Cytology confirmed pulmonary adenocarcinoma. A splenic myelolipoma, unrelated to the primary pulmonary tumor, was identified incidentally and surgically removed. Treatment included vinorelbine-based chemotherapy and cytokine-based immunotherapy using interleukin (IL)-15, IL-12, IL-23, and selenium. After temporary discontinuation due to adverse events, cytokine monotherapy was administered, followed by resumed combination therapy upon stage IV progression with contralateral lung metastasis. Radiographic follow-up demonstrated disease stabilization during monotherapy and prolonged survival with combination therapy. The dog survived for 241 days, including 143 days after stage IV diagnosis, exceeding previously reported outcomes. Although NK cell function was not directly evaluated, these findings raise the possibility that cytokine-based NK cell immunotherapy, when combined with chemotherapy, could have contributed to disease control and prolonged survival in advanced canine pulmonary adenocarcinoma.<\/jats:p>","DOI":"10.3390\/ani15223330","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:02:13Z","timestamp":1763546533000},"page":"3330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Case Report of Advanced Pulmonary Adenocarcinoma in a Dog Managed with Chemotherapy and Cytokine-Based Immunotherapy"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3442-8216","authenticated-orcid":false,"given":"Kyu-Duk","family":"Yeon","sequence":"first","affiliation":[{"name":"Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea"},{"name":"SNC Animal Medical Center, 416 Nonhyeon-ro, Gangnam-gu, Seoul 06134, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hyuk","family":"Seo","sequence":"additional","affiliation":[{"name":"SNC Animal Medical Center, 416 Nonhyeon-ro, Gangnam-gu, Seoul 06134, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-3266","authenticated-orcid":false,"given":"Jung-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rose, R.J., and Worley, D.R. (2020). A contemporary retrospective study of survival in dogs with primary lung tumors: 40 cases (2005\u20132017). Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.519703"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/vco.12582","article-title":"Retrospective evaluation of a modified human lung cancer stage classification in dogs with surgically excised primary pulmonary carcinomas","volume":"18","author":"Lee","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rinaldi, V., Finotello, R., Boari, A., Cabibbo, E., and Crisi, P.E. (2023). Vinorelbine as first-line treatment in stage IV canine primary pulmonary carcinoma. Vet. Sci., 10.","DOI":"10.3390\/vetsci10120664"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/vco.12393","article-title":"Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide","volume":"16","author":"Polton","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: From basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: Implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4049\/jimmunol.153.4.1697","article-title":"Recombinant IL-12 administration induces tumor regression in association with IFN-\u03b3 production","volume":"153","author":"Nastala","year":"1994","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e004493","DOI":"10.1136\/jitc-2022-004493","article-title":"Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: A phase 1 study of clinical activity and correlates of response","volume":"10","author":"Rebhun","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3892\/or.2021.8183","article-title":"Natural killer cell-based immunotherapy for lung cancer: Challenges and perspectives (Review)","volume":"46","author":"Zeng","year":"2021","journal-title":"Oncol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/vco.12677","article-title":"Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats","volume":"19","author":"LeBlanc","year":"2021","journal-title":"Vet. Comp. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_12","first-page":"S99","article-title":"Pneumothorax after transthoracic needle biopsy of lung lesions under CT guidance","volume":"6","author":"Boskovic","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e142S","DOI":"10.1378\/chest.12-2353","article-title":"American College of Chest Physicians evidence-based clinical practice guidelines. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Rivera","year":"2013","journal-title":"Chest J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/RCT.0000000000000154","article-title":"Lung cancer associated with cystic airspaces","volume":"39","author":"Mascalchi","year":"2015","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5455\/OVJ.2023.v13.i2.13","article-title":"Giant and potentially malignant bullae in a dog","volume":"13","author":"Roque","year":"2023","journal-title":"Open Vet. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00595-017-1577-8","article-title":"The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer","volume":"48","author":"Takenaka","year":"2018","journal-title":"Surg. Today"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"357ra123","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1182\/blood-2012-04-419283","article-title":"Cytokine activation induces human memory-like NK cells","volume":"120","author":"Romee","year":"2012","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ziblat, A., Nu\u00f1ez, S.Y., Raffo Iraolagoitia, X.L., Spallanzani, R.G., Torres, N.I., Sierra, J.M., Secchiari, F., Domaica, C.I., Fuertes, M.B., and Zwirner, N.W. (2018). Interleukin (IL)-23 stimulates IFN-\u03b3 secretion by CD56 bright natural killer cells and enhances IL-18-driven dendritic cell activation. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01959"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"He, L., Zhang, L., Peng, Y., and He, Z. (2025). Selenium in cancer management: Exploring the therapeutic potential. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1490740"}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/15\/22\/3330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:23:39Z","timestamp":1763547819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/15\/22\/3330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":20,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ani15223330"],"URL":"https:\/\/doi.org\/10.3390\/ani15223330","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]}}}